Skip to main content

Table 4 Stratified analysis of odds ratios (95% Confidence intervals) for MetS and its components according to serum Gly levels (per 1-SD increment)

From: Association of serum glycine levels with metabolic syndrome in an elderly Chinese population

 

<65y

P

≥65y

P

Per SD increment

Per SD increment

MetS

 Model 1 a

0.92 (0.60–1.42)

0.711

0.71 (0.55–0.91)

0.006

 Model 2 b

0.92 (0.60–1.41)

0.695

0.65 (0.50–0.83)

0.001

 Model 3 c

0.89 (0.54–1.46)

0.642

0.66 (0.51–0.86)

0.002

Central obesity

 Model 1 a

0.77 (0.50–1.18)

0.236

0.79 (0.64–0.98)

0.028

 Model 2 b

0.74 (0.48–1.15)

0.183

0.67 (0.54–0.85)

0.001

 Model 3 c

0.69 (0.43–1.12)

0.130

0.67 (0.52–0.86)

0.002

Hypertriglyceridemia

 Model 1 a

1.14 (0.71–1.83)

0.586

0.77 (0.59–0.99)

0.046

 Model 2 b

1.11 (0.69–1.78)

0.668

0.70 (0.53–0.91)

0.007

 Model 3 c

1.15 (0.70–1.88)

0.574

0.72 (0.55–0.94)

0.016

Hypo-HDL-cholesterolemia

 Model 1 a

1.47 (0.94–2.31)

0.092

0.74 (0.56–0.99)

0.043

 Model 2 b

1.44 (0.90–2.28)

0.127

0.69 (0.51–0.92)

0.012

 Model 3 c

1.44 (0.88–2.35)

0.145

0.69 (0.51–0.94)

0.018

Hypertension

 Model 1 a

0.97 (0.62–1.53)

0.893

0.95 (0.75–1.19)

0.633

 Model 2 b

0.96 (0.60–1.52)

0.850

0.95 (0.75–1.20)

0.679

 Model 3 c

0.97 (0.60–1.57)

0.890

0.94 (0.74–1.21)

0.633

Impaired fasting glucose

 Model 1 a

0.98 (0.64–1.51)

0.926

0.83 (0.67–1.02)

0.074

 Model 2 b

0.98 (0.63–1.51)

0.924

0.88 (0.70–1.09)

0.232

 Model 3 c

0.97 (0.61–1.55)

0.909

0.92 (0.73–1.16)

0.490

  1. aModel 1: Crude risk for MetS
  2. bModel 2: Adjusted for age and gender
  3. cModel 3: Further adjusted for smoking status; alcohol drinking; CRP; and family history of diabetes, hypertension, and CAD